Skip to main content
. 2016 Jul 7;56(Suppl Suppl 7):S132–S142. doi: 10.1002/jcph.669

Table 2.

Details of the Clinical OATP1B1 Polymorphism Study Design by Pasanen et al13 Used for Performance Verification of the OATP1B1 Phenotype Component of the Rosuvastatin PBPK Model*

OATP1B1 Number of Age Range Proportion
Genotype Subjects (Years) Female
c.521TT 16 20‐23 0.5
c.521TC 12 21‐24 0.42
c.521CC 4 20‐23 0.25

*A single oral dose of 10 mg rosuvastatin was administered.